Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.

Saved in:
Bibliographic Details
Title: Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy.
Authors: Jeon YH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Lee N; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea., Yoo J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Won S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Shin SK; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Kim KH; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea., Park JG; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea., Kim MG; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Kim HR; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea., Oh K; SillaJen, Inc. Research Center, Seongnam-si 13493, Korea., Lee DS; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.; Wide River Institute of Immunology, Seoul National University, Hongcheon-gun 25159, Korea.
Source: Biomedicines [Biomedicines] 2022 Mar 30; Vol. 10 (4). Date of Electronic Publication: 2022 Mar 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2227-9059
DOI:10.3390/biomedicines10040805